Swiss National Bank’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-86,950
| Closed | -$6.94M | – | 2666 |
|
|
2021
Q1 | $6.94M | Buy |
86,950
+1,000
| +1% | +$78.1K | ﹤0.01% | 1250 |
|
|
2020
Q4 | $6.78M | Hold |
85,950
| – | – | ﹤0.01% | 1165 |
|
|
2020
Q3 | $3.78M | Buy |
85,950
+500
| +0.6% | +$24.6K | ﹤0.01% | 1356 |
|
|
2020
Q2 | $3.78M | Buy |
85,450
+11,100
| +15% | +$414K | ﹤0.01% | 1315 |
|
|
2020
Q1 | $2.67M | Buy |
74,350
+2,500
| +3% | +$142K | ﹤0.01% | 1278 |
|
|
2019
Q4 | $5.09M | Buy |
71,850
+1,200
| +2% | +$87K | 0.01% | 1145 |
|
|
2019
Q3 | $5.29M | Buy |
70,650
+800
| +1% | +$67.8K | 0.01% | 1063 |
|
|
2019
Q2 | $5.63M | Buy |
69,850
+1,400
| +2% | +$98.4K | 0.01% | 1052 |
|
|
2019
Q1 | $4.58M | Buy |
68,450
+2,100
| +3% | +$159K | 0.01% | 1135 |
|
|
2018
Q4 | $4.94M | Buy |
66,350
+800
| +1% | +$66K | 0.01% | 986 |
|
|
2018
Q3 | $6.04M | Hold |
65,550
| – | – | 0.01% | 994 |
|
|
2018
Q2 | $6.45M | Hold |
65,550
| – | – | 0.01% | 941 |
|
|
2018
Q1 | $7.3M | Buy |
65,550
+1,600
| +3% | +$179K | 0.01% | 844 |
|
|
2017
Q4 | $6.58M | Buy |
63,950
+1,100
| +2% | +$110K | 0.01% | 884 |
|
|
2017
Q3 | $5.92M | Hold |
62,850
| – | – | 0.01% | 923 |
|
|
2017
Q2 | $4.9M | Buy |
62,850
+1,100
| +2% | +$82.6K | 0.01% | 1012 |
|
|
2017
Q1 | $4.95M | Hold |
61,750
| – | – | 0.01% | 989 |
|
|
2016
Q4 | $4.86M | Buy |
61,750
+1,000
| +2% | +$77.7K | 0.01% | 970 |
|
|
2016
Q3 | $4.74M | Sell |
60,750
-1,200
| -2% | -$87.1K | 0.01% | 940 |
|
|
2016
Q2 | $4.26M | Buy |
61,950
+3,100
| +5% | +$214K | 0.01% | 1005 |
|
|
2016
Q1 | $4.05M | Buy |
58,850
+11,700
| +25% | +$734K | 0.01% | 998 |
|
|
2015
Q4 | $2.93M | Hold |
47,150
| – | – | 0.01% | 1086 |
|
|
2015
Q3 | $2.67M | Buy |
47,150
+6,000
| +15% | +$318K | 0.01% | 1122 |
|
|
2015
Q2 | $2.21M | Buy |
41,150
+700
| +2% | +$34K | 0.01% | 1247 |
|
|
2015
Q1 | $1.92M | Buy |
40,450
+500
| +1% | +$22.1K | 0.01% | 1314 |
|
|
2014
Q4 | $1.73M | Buy |
39,950
+900
| +2% | +$36.8K | 0.01% | 1361 |
|
|
2014
Q3 | $1.34M | Sell |
39,050
-700
| -2% | -$24.7K | 0.01% | 1476 |
|
|
2014
Q2 | $1.46M | Hold |
39,750
| – | – | 0.01% | 1479 |
|
|
2014
Q1 | $1.34M | Buy |
39,750
+8,900
| +29% | +$294K | 0.01% | 1503 |
|
|
2013
Q4 | $1.05M | Hold |
30,850
| – | – | ﹤0.01% | 1475 |
|
|
2013
Q3 | $983K | Sell |
30,850
-2,600
| -8% | -$69.1K | ﹤0.01% | 1454 |
|
|
2013
Q2 | $755K | Buy |
+33,450
| New | +$724K | ﹤0.01% | 1621 |
|
Swiss National Bank's CMD Position: Q2 2021 in Review
Swiss National Bank sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 86,950 shares — an estimated $6.94M sold.
Swiss National Bank first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $7.3M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Swiss National Bank reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Swiss National Bank sold 86,950 Cantel Medical Corporation shares in Q2 2021, an estimated $6.94M.
- Swiss National Bank first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Swiss National Bank's Cantel Medical Corporation position peaked at $7.3M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.